– USA, MA – DataRobot, Inc., the leader in automated machine learning, today announced the addition of Hilarie Koplow-McAdams, Venture Partner at New Enterprise Associates, to its Board of Directors.
Koplow-McAdams brings an extensive background in supporting high-growth enterprise software companies and joins DataRobot’s seven other board members as they work to accomplish the organization’s mission of expanding globally and vertically to increase its service offerings.
“As a leader at Salesforce.com, Hilarie helped bring the ‘Sales Cloud’ to the world,” said Jeremy Achin, DataRobot Co-Founder, and CEO. “Now she will help DataRobot bring the ‘AI Cloud’ to every industry, geography, and business – from the smallest SMBs to the Fortune 10. Hilarie’s operating experience and track record make her the ideal Board Director for DataRobot, and I look forward to her guidance and mentorship.”
About Hilarie Koplow-McAdams
Prior to joining NEA in 2017, Koplow-McAdams was Chief Revenue Officer and then President at New Relic, a software analytics and real-time insights startup. There, she was directly responsible for the company’s growth and oversight of global sales, marketing, customer success, support, and business development. Under her leadership, the company achieved its IPO in December 2014 and raised $115 million as a result.
In addition to her experience scaling software startups, Koplow-McAdams also holds decades’ worth of experience at established technology firms like Salesforce, Intuit, and Oracle. Koplow-McAdams served as President at Salesforce, where she oversaw the success of the company’s worldwide sales teams and helped it achieve record-breaking revenue growth. She began her career at Oracle, where she held a variety of strategic roles over the course of 18 years, including Senior Vice President of Oracle Direct. In that role, she drove the company’s rapid expansion in both the technology and applications markets.
DataRobot has grown significantly since its founding in 2012. NEA participated in the company’s $100 million Series D in October 2018, bringing DataRobot’s total funding to $225 million. Most recently, the company appointed several new key executives – including Igor Taber to Senior Vice President of Corporate Development and Strategy, Eric Forseter to General Manager of Public Sector, and Colleen Greene to General Manager of Healthcare – who will jointly contribute to scaling the company and extending the reach of its disruptive solution.
“Machine learning is undoubtedly one of the most coveted software tools on the market today,” said Koplow-McAdams. “DataRobot’s unique approach to automating machine learning is helping organizations enhance their data science capabilities so they can glean optimal intelligence more efficiently than ever before. I’m thrilled to be joining such an innovative company and look forward to working with the rest of the Board to support DataRobot’s continued growth.”
DataRobot is the category creator and leading provider of automated machine learning. Organizations worldwide use DataRobot to empower the teams they already have in place to rapidly build and deploy machine learning models and create advanced AI applications. With a library of hundreds of the most powerful open source machine learning algorithms, the DataRobot platform encapsulates every best practice and safeguard to accelerate and scale data science capabilities while maximizing transparency, accuracy, and collaboration.
By making data scientists more productive and enabling the democratization of data science, DataRobot helps organizations transform into AI-driven enterprises. With offices around the globe, DataRobot is backed by $225 million in funding from top-tier firms, including New Enterprise Associates, Sapphire Ventures, Meritech, and DFJ.
For more information: https://www.datarobot.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.